logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
K

Karen L. Reckamp

samuel oschin comprehensive cancer institute

63H-index
543Paper Count
2.9WCitation Count
Published Papers 153
Publication Date
logo
Insights on supplement use during cancer care from online Reddit conversations
errBMC Complementary Medicine and Therapies
IF3.4
err2026-07-25
err0
errOAAI
errBarliz Waissengrin; Karen O’Connor; Celina H. Shirazipour; Flores Amaro Ivan; Karen L. Reckamp; Graciela Gonzalez-Hernandez; Jane C. Figueiredo
errShare
errSave
PP01.118: Phase 1b/2 trial of BNT324/DB-1311 (B7H3 ADC) with Pumitamig (BNT327; PD-L1 x VEGF-A bsAb) in Lung Cancer (SCLC or NSCLC): BNT324-01 Trial in Progress
errJournal of Thoracic Oncology
IF20.8
err2026-05-07
err0
PREAI
errAdam Schoenfeld; Alexander Spira; Aaron E. Lisberg; Martin E. Gutierrez; Kamlesh Sankhala; Margaret Byrne; Karen L. Reckamp; Angel Qin; Thomas U. Marron; Kartik Konduri; Donald A. Richards; John Paschold; Clifton Layman; Erin L. Schenk; Kaushal Parikh; Yanyan Lou; Vinicius Ernani; Alex Adjei; Mehmet Altan; Yang Qiu
errShare
errSave
Pre-vaccine immune profiling in cancer patients identifies correlates of COVID-19 vaccine responses
errHuman Vaccines and Immunotherapeutics
IF3.5
err2025-12-31
err0
PREAI
errKazerani, Maryam; Mahov, Simeon; Foley, Joslyn; Merin, Noah M.; Choi, So Yung; Lownik, Joseph; Xu, Alexander M.; Milshteyn, Larry; Villamejor, Anton Luis; Nadri, Maimoona; Nguyen, Nathalie; Kazemian, Elham; Hamid, Omid; Darrah, Justin; Gong, Jun; Paquette, Ronald; Vescio, Robert; Mehmi, Inderjit; Tourtellotte, Warren G.; Ramanujan, V. Krishnan; Reckamp, Karen L.; Figueiredo, Jane C.; Merchant, Akil
errShare
errSave
The Expanding Landscape of Next-Generation EGFR Tyrosine Kinase Inhibitors: Have We Reached Capacity?
errJournal of Thoracic Oncology
IF20.8
err2025-11-05
err0
PREAI
errKamya Sankar; Barliz Waissengrin; Karen L. Reckamp
errShare
errSave
In the time of COVID-19: challenges, successes, and lessons learned from studies in cancer patients
errJNCI: Journal of the National Cancer Institute
IF0
err2025-08-01
err0
PREAI
errPhilip C Mack, PhD; James M Crawford, MD, PhD; Andres Chang, MD; Anna Yin, MPH; Sabra L Klein, PhD; Patrick Shea, MSPH; Fred R Hirsch, MD, PhD; David Zidar, MD, PhD; Viviana Simon, MD, PhD; Charles Gleason, BS; Russell McBride, PhD; Carlos Cordon-Cardo, PhD; Jennifer VanOudenhove, PhD; Stephanie Halene, MD; F Eun-Hyung Lee, MD; Nicholas Mantis, PhD; Lawrence H Kushi, ScD; Daniela Weiskopf, PhD; Akil Merchant, MD; Karen L Reckamp, MD; Jacek Skarbinski, MD; Jane C Figueiredo, PhD
errShare
errSave
Enhancing management of pancreatic cancer: impact of a same day multidisciplinary clinic on access to guideline-directed care
errHPB
IF2.4
err2025-07-17
err0
errOAAI
errMatthew I. Ebia; Anser A. Abbas; Abrahm Levi; John Davelaar; Elissa Rosenberg; Katelyn M. Atkins; Mitchell Kamrava; Simon Lo; Srinivas Gaddam; Alexandra Gangi; Kambiz Kosari; Arpit Arora; Nanor Haladjian; Meghan Laszlo; Steven Oppenheim; Karen L. Reckamp; Nicholas Nissen; Brent K. Larson; Ashley Wachsman; Jun Gong; Cristina Ferrone; Andrew E. Hendifar; Arsen Osipov
errShare
errSave
50 years of Progress in Non-Small Cell Lung Cancer: A New Fellow’s Guide in the Clinic
errJournal of Thoracic Oncology
IF20.8
err2025-07-03
err0
PREAI
errJarushka Naidoo; Abesh Niroula; Dipesh Uprety; Matthew Smeltzer; Nicole Geissen; Raymond U. Osarogiagbon; Mari Mino-Kenudson; Yasushi Yatabe; Kristin Higgins; Aakash Desai; Karen L. Reckamp; Jessica Jiyeong Lin; Stephen V. Liu; Fiona Hegi-Johnson Franzcr; Nagashree Seetharamu; David Harpole; Martin J. Edelman
errShare
errSave
CD105 blockade restores osimertinib sensitivity in drug-resistant EGFR-mutant non-small cell lung cancer
errDRUG RESISTANCE UPDATES
IF21.7
err2025-07-01
err0
errOAAI
errThiruvalluvan, Manish; Billet, Sandrine; Liu, Zhenqiu; Lownik, Joseph; Waissengrin, Barliz; Kim, Hyoyoung; Villamejor, Anton L.; Milshteyn, Larry; Li, Xiamo; Gayhart, Matthew; Arana, Manuel; Sankar, Kamya; Posadas, Edwin M.; Lopategui, Jean; You, Sungyong; Reckamp, Karen L.; Bhowmick, Neil A.
errShare
errSave
Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive Non–Small-Cell Lung Cancer According to ALK Fusion and Mutation Status
errClinical Lung Cancer
IF3.3
err2025-06-06
err0
errOAAI
errLyudmila Bazhenova; J.G. Hodgson; D. Ross Camidge; Corey J. Langer; Rudolf M. Huber; Dong-Wan Kim; Karen L. Reckamp; Myung-Ju Ahn; Daniel S.W. Tan; Jyoti D. Patel; Sylvie Vincent; Cong Li; Michael J. Humphries; Pingkuan Zhang; Victor M. Rivera; Scott Gettinger
errShare
errSave
An evaluation of patritumab deruxtecan for the treatment of EGFR-mutated non-small cell lung cancer
errEXPERT OPINION ON BIOLOGICAL THERAPY
IF4
err2025-05-22
err0
PREAI
errWaissengrin, Barliz; Reckamp, Karen L.
errShare
errSave
Plain language summary of MARIPOSA-2: amivantamab-chemotherapy either with or without lazertinib for treatment of non-small-cell lung cancer
errFUTURE ONCOLOGY
IF2.6
err2025-05-06
err0
errOAAI
errPassaro, Antonio; Cortot, Alexis B.; Gentzler, Ryan D.; Reckamp, Karen L.; Shah, Sujay; William, William Nassib; Cho, Byoung Chul
errShare
errSave
Afatinib and Necitumumab in EGFR-Mutant NSCLC with Acquired Resistance to Tyrosine Kinase Inhibitors
errJTO CLINICAL AND RESEARCH REPORTS
IF3.5
err2025-02-01
err0
PREAI
errMyall, Nathaniel J.; Whisenant, Jennifer G.; Neal, Joel W.; Iams, Wade T.; Reckamp, Karen L.; York, Sally; Berry, Lynne D.; Shyr, Yu; Horn, Leora; Wakelee, Heather A.; Padda, Sukhmani K.
errShare
errSave
Cardiac events and dynamic echocardiographic and electrocardiogram changes following osimertinib treatment in lung cancer
errFRONTIERS IN CARDIOVASCULAR MEDICINE
IF2.9
err2024-12-16
err0
errOAAI
errLe, Jonathan N.; Gasho, Jordan O.; Peony, Olivia; Singh, Asneh; Silos, Katrina D.; Kim, Sungjin; Nguyen, Anthony T.; Kamrava, Mitchell; Mirhadi, Amin; Hakimian, Behrooz; Reckamp, Karen L.; Sankar, Kamya; Mak, Raymond H.; Nikolova, Andriana P.; Atkins, Katelyn M.
errShare
errSave
EGFR-mediated HSP70 phosphorylation facilitates PCNA association with chromatin and DNA replication
errNUCLEIC ACIDS RESEARCH
IF13.1
err2024-10-29
err0
errOAAI
errWang, Yingying; Fernandez, Anthony; Pei, Xinyu; Liu, Bing; Shen, Lei; Yan, Yao; Solanki, Hitendra S.; Yang, Lin; Zhou, Mian; Guo, Yuming; Wu, Jun; Reckamp, Karen L.; Zheng, Li; Shen, Binghui
errShare
errSave
A genomic scar based signature (HRDsig) and biallelic BRCA alterations identify a homologous recombination deficiency (HRD) phenotype of non-small cell lung cancer (NSCLC) potentially actionable to the PARP inhibitor rucaparib: Post-hoc analysis of lung-MAP substudy S1900A
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errRiess, J. W.; Miao, J.; Wheatley-Price, P.; Reckamp, K. L.; Kozono, D.; Redman, M. W.; Edelman, M. J.; Faller, B.; Villaruz, L.; Corum, L.; Gowda, A.; Srkalovic, G.; Osarogiagbon, R.; Baumgart, M.; Gandara, D. R.; Sokol, E. S.; Borghaei, H.; Gray, J. E.; Herbst, R. S.; Kelly, K.
errShare
errSave
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic or Unresectable EGFR-Mutated Non-Small Cell Lung Cancer Previously Treated with Osimertinib and Platinum-Based Chemotherapy
errADVANCES IN THERAPY
IF4
err2024-07-03
err1
errOAAI
errPatel, Jyoti; Meng, Jie; Le, Hoa; Tanaka, Yoko; Phani, Sudarshan; Salas, Maribel; Wu, Chuntao; Sternberg, David; Esker, Stephen; Anderson, Jeffrey P.; Crowley, Aaron; Zhou, Summera Q.; Lieb, Camryn; Sun, Haiyan; Doan, Quan V.; Santhanagopal, Anu; Reckamp, Karen L.
errShare
errSave
Targeting slow-cycling persisters in EGFR mutant non-small cell lung cancer
errCANCER RESEARCH
IF16.6
err2024-03-22
err0
PREAI
errThiruvalluvan, Manish; Billet, Sandrine; Liu, Zhenqiu; Lownik, Joseph; Gonzales, Gabrielle; Kim, Hyoyoung; Villamejor, Anton L.; Milshteyn, Larry; Sankar, Kamya; Posadas, Edwin M.; Lopategui, Jean; You, Sungyong; Reckamp, Karen; Bhowmick, Neil A.
errShare
errSave
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
errANNALS OF ONCOLOGY
IF65.4
err2024-01-01
err101
errOAAI
errPassaro, A.; Wang, J.; Wang, Y.; Lee, S. -H.; Melosky, B.; Shih, J. -Y.; Wang, J.; Azuma, K.; Juan-Vidal, O.; Cobo, M.; Felip, E.; Girard, N.; Cortot, A. B.; Califano, R.; Cappuzzo, F.; Owen, S.; Popat, S.; Tan, J. -l.; Salinas, J.; Tomasini, P.; Gentzler, R. D.; William, W. N.; Reckamp, K. L.; Takahashi, T.; Ganguly, S.; Kowalski, D. M.; Bearz, A.; MacKean, M.; Barala, P.; Bourla, A. B.; Girvin, A.; Greger, J.; Millington, D.; Withelder, M.; Xie, J.; Sun, T.; Shah, S.; Diorio, B.; Knoblauch, R. E.; Bauml, J. M.; Campelo, R. G.; Cho, B. C.
errShare
errSave
OsimertinibAssociated Cardiotoxicity: Insights Into Echocardiographic Changes and Patients at Increased Risk
errCIRCULATION
IF38.6
err2023-11-07
err0
PREAI
errLe, Jonathan N.; Gasho, Jordan O.; Peony, Olivia; Singh, Asneh; Silos, Katrina; Kim, Sungjin; Nguyen, Anthony; Reckamp, Karen L.; Sankar, Kamya; Nikolova, Andriana P.; Atkins, Katelyn M.
errShare
errSave
Amivantamab plus chemotherapy (with or without lazertinib) vs chemotherapy in EGFR-mutated advanced NSCLC after progression on osimertinib: MARIPOSA-2, a phase III, global, randomized, controlled trial
errANNALS OF ONCOLOGY
IF65.4
err2023-10-01
err6
errOAAI
errPassaro, A.; Cho, B. C.; Wang, Y.; Melosky, B.; Califano, R.; Lee, S-H.; Girard, N.; Reckamp, K. L.; Takahashi, T.; Felip, E.; Gentzler, R. D.; Popat, S.; William, W. Nassib, Jr.; Sun, T.; Shah, S.; Diorio, B.; Knoblauch, R. E.; Bauml, J. M.; Garcia-Campelo, M. R.; Wang, J.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
P
Pasi A. Jänne
H-index: 163 · Papers: 2.3K
C
Carlos Cordon‐Cardo
H-index: 154 · Papers: 936
M
Mark G. Kris
H-index: 149 · Papers: 1.4K
P
Perminder S. Sachdev
H-index: 147 · Papers: 1.8K
J
Josep Tabernero
H-index: 146 · Papers: 2.7K
View more